Tuesday, April 2, 2019

Cramer: Wall Street will get flooded with IPOs if we don't see more mergers

Wall Street needs to see more mergers and acquisitions come through before the "coming onslaught" of initial public offerings jams up investing capital, CNBC's Jim Cramer said Tuesday.

Major U.S. indexes traded strong out the gate Tuesday, but gave up most of their gains before the close. The Dow Jones Industrial Average added more than 140 points in Tuesday's session. The S&P 500 and tech-heavy Nasdaq both gained about 0.70 percent.

"I think part of it is that we've got too many stocks," the "Mad Money" host said. "So with a bunch of new IPOs on the horizon, the market won't be able to handle all the supply. And when supply outstrips demand, prices go lower."

Lyft will list on the Nasdaq Friday. AirBNB and Uber plan to go public this year, and Slack, Palantir, and WeWork could join the fray as well.

Cramer predicted FAANG stocks would fall under pressure if there is not enough money to go around. The FAANG group includes Facebook, Apple, Amazon, Netflix, and Alphabet's Google.

"I think the FAANG stocks will be used a source of funds," he said.

But big tech is not the only sector that the host is worried about. He said the oil, cloud, health care and transports sectors, among others, are too crowded and need some consolidation.

"I wouldn't be this concerned about the lack of mergers if I weren't so worried about the coming onslaught of IPOs," he said. "If money managers want to participate in these deals—and they will—they need to sell stocks that they already own to raise money ... and that's gonna put pressure on the whole market."

Below are some potential deals that would get Cramer excited:

Oil

"I think the mid-sized independent producers need to band together in order to cut costs," and a marriage of Apache and Anadarko would make sense, Cramer said.

A major oil company, the likes of BP, Exxon, or Chevron, could make a play for Occidental Petroleum, "which has the best acreage in the booming, low-cost Permian Basin," he said.

Cloud computing

There are too many cloud stocks, the "Mad Money" host said, adding that he has has had plenty of cloud company CEOs on the show. IBM is buying Red Hat and the host said it may inspire more consolidation once the $34 million deal closes. Furthermore, Red Hat's latest quarterly report justifies the "huge premium" that the computer builder paid for the open-source software maker, he added.

"In retrospect, IBM may have actually gotten a bargain with Red Hat, even as the deal looked like a wild overpay at the time," he said.

Health and managed care

The CVS-Aetna merger left a bad taste in many investors' mouths, but Cramer said CEO Larry Merlo told a compelling story on "Mad Money" last week.

"If Merlo can execute, I think the health insurers wind up wishing they'd made some deals right here," he said. "I'm betting today's sell-off will mark the lows here."

Cramer also said he thinks drug distributors Cardinal Health and McKesson should consolidate.

Payments

Cramer said the crowded payments sector is in dire need of consolidation. He suggested Facebook could make a play for Square or PayPal.

"They need a revenue stream away from social media now that they've gotten religion about not selling you out as a business," he said.

American Express has been strong, but the company should also go after Square so the financial services firm can own the register, he said.

Fidelity National bought payment processor Worldpay for $35 billion and Fiserv bought First Data for $22 billion, Cramer highlighted.

Transports and deliveries

FedEx or UPS could pick up XPO Logistics, Cramer said.

"I've been a fan of XPO Logistics ... but there are too many companies in the delivery business," he said. "XPO's stock has lost more than half of its value in the last six months."

On the food delivery side, Postmates and Uber Eats will soon join Grubhub and Square's Caviar on the public market. Doordash is also another top competitor in the industry.

"If I were GrubHub, I'd try to snap up Square's non-core Caviar business," he said. "I bet both stocks would rally."

Disclosure: Cramer's charitable trust owns shares of Apple, Amazon, and Facebook.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Thursday, March 28, 2019

El-Erian: Absent a 'policy mistake,' there's 'no way' US will have a recession this year or in 2020

The United States will not head into a recession this year or in 2020 as long as there's not a "major policy mistake" from the Federal Reserve, widely followed economist Mohamed El-Erian told CNBC on Tuesday.

The "peculiar" technicals in the market have to do with Europe and what's happening with the Fed, Allianz's chief economic advisor told "Squawk Box." "This economy, unless it's disrupted by a major policy mistake, is on its way to 2.5 to 3 percent growth for this year."

El-Erian said he was concerned that the Fed last week essentially sidelined itself on interest rate hikes for this year.

"I wouldn't give up policy optionality so early," he said. "There's lot of uncertainty. It's not clear how this divergent growth is going to play out."

El-Erian's remarks are at odds with a growing list of economists and business elite predicting a downturn, as well as warning signs from the bond market.

Most economists, as well as some the world's business elite, agree that U.S. economic growth is slowing, and some predict that the global economy is headed for a recession as soon as this year.

Mohamed El-Erian 190326 Anjali Sundaram | CNBC Mohamed El-Erian 190326

Economists see on average a 25 percent chance of a recession within 12 months, according to a Wall Street Journal survey published in January, the highest level since October 2011 and up from just 13 percent last year.

On Friday, markets were spooked when the yield curve inverted, meaning interest rates on short-term bonds rose above those of 10-year notes, a fairly reliable recession signal. Traders say the bond market may be overreacting, while stocks seem to be ignoring the recession warnings.

El-Erian, former CEO and co-CIO of Pimco, sees signs that the economy actually has momentum. He said that while President Donald Trump's 2017 tax stimulus is weakening, business investment is picking up and the labor market is strong. "We still have job creation well above what'd you expect this time in the cycle," El-Erian said.

"There's no way there's going to be a recession," he added.

--CNBC's Patti Domm contributed to this report.

Saturday, March 23, 2019

Maruti Suzuki falls 4% amid production cut buzz

Maruti Suzuki shares fell more than 4 percent intraday and the stock was the biggest loser among Nifty50 counters on Monday after a media report indicated that the slow demand prompted the company to cut its production in March.

The stock was quoting at Rs 6,815.00, down Rs 277.05, or 3.91 percent on the BSE, at 10:56 hours IST.

"A slowing demand in India's passenger vehicle market has prompted the car market leader, Maruti Suzuki India, to cut production by a quarter over March last year," Business Standard said quoting people aware of the company's plans.

Maruti is estimated to have cut production to around 1,26,000 units as compared to more than 1,72,000 units a year ago, which is a 26.8 percent reduction, the report added. Hence, production in March 2019 is expected to be lowest since March 2015.

related news Bombay Dyeing surges 11% as Mumbai project gets nod IRB Infra falls after rising nearly 2% as it commissions highway project Lumax Auto Technologies slips nearly 3% as co shuts PCB manufacturing

This is in sharp contrast to a positive trend in the past several years, including double-digit growth for the last four years.

Demand uncertainties and switch to stricter emission norms leads to slowdown, the report said.

Production cut comes amidst falling sales in current financial year when domestic sales grew only 6.2 percent YoY.

In February, Maruti's overall volumes grew by 1 percent YoY to 1,48,682 units with domestic sales rising a percent and exports falling 20 percent YoY.

Entry and compact segment volumes declined by 2 percent YoY. Ciaz volumes declined by 37 percent YoY, SUV volumes were up 7 percent YoY led possibly by the launch of new Ertiga and vans segment volumes grew by 17 percent YoY. First Published on Mar 18, 2019 12:16 pm

Monday, March 18, 2019

Huazhu Group Limited (HTHT) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

Huazhu Group Limited  (NASDAQ:HTHT)Q4 2018 Earnings Conference CallMarch 14, 2019, 9:00 p.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Ladies and gentlemen, thank you for standing by and welcome to Huazhu Group Limited Quarter Four 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. There'll be a presentation followed by a question-and-answer session. (Operator Instructions) And I must advise you that this conference is being recorded today, the 15th of March 2019.

I would now like to hand the conference over to your speaker today, Ida Yu. Thank you. Please go ahead.

Ida Yu -- Investor Relations Manager

Thank you, Richie. Good morning, everyone. Thanks to all of you for dialing in and welcome to our fourth quarter and full year 2018 earnings conference call. Joining us today is Mr. Qi Ji, our Founder and Executive Chairman; Ms. Jenny Zhang, our CEO; and Mr. Teo Nee Chuan, our CFO. Jenny and Teo will present the strategy review and the Q4 full year results. Following their prepared remarks, Management will be available to answer your questions.

Before we continue please note that the discussion today will include forward-looking statements made under the Safe Harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements involve inherent risks and uncertainties. As such, our results may be materially different from the views expressed today. A number of potential risks and uncertainties are outlined in our public filings with the SEC. Huazhu Group does not undertake any obligation to update any forward-looking statements, except as required under applicable law.

On the call today, we will also mention adjusted financial measures during the discussion of our performance. Reconciliations of those measures to compatible GAAP information can be found in the earnings release that was distributed earlier today. As a reminder, this conference call is being recorded. The webcast of this conference call, as well as supplementary slide presentation is available on the Investor Relations section of Huazhu Group's website at ir.huazhu.com.

Now, I would like to turn the call over to Jenny. Jenny, please?

Min Zhang -- Chief Executive Officer

Good morning, everyone. I'm pleased to report that Huazhu has delivered very strong results for 2018. To help all investors apprehend the scale of our business in different of leased and managed models, we introduced a new metric called hotel turnover, which for managed and the franchised hotels reflect the total revenue captured at hotel level instead of fees charged by Huazhu.

As shown on Page 2, our hotel turnover increased by 23% to RMB29.7 billion in 2018. Our net revenues stood at RMB10 billion, a year-over-year increase of 22%, exceeding the high end of our guidance. Our adjusted EBITDA grew by 37% with a margin of 32.5%, up 3.6 percentage points from 28.9% last year. The adjusted net income increased by 36% with a margin of 17%, up 1.7 percentage points from 15.3% last year. Teo will provide (technical difficulty) analysis later.

Our robust top line growth is driven by both hotel network expansion and RevPAR growth, as illustrated on Page 3. In 2018, Huazhu's number of hotels in operation expanded by 13% net to 4,230 hotels.. Our Group blended RevPAR increased by 10%, as a combined result of the RevPAR growth for mature hotel and the new hotel mix shift to midscale and upscale segment.

Looking forward into 2019, we remain confident that our hotel expansion will accelerate on the back of our strong pipeline growth. On Page 4, our pipeline reached a new record of 1,105 hotels at the end of 2018. This represented 26% of hotels in operation at the end of 2018 significantly higher than 19% at the end of 2017 and 14% at the end of 2016. Approximately 80% of rooms in pipeline are under midscale and upscale brands. Our asset-light model of manachised and the franchised have been our primary business model. Our powerful brand and the loyalty program continued to add value to our franchisees. We consistently grow our hotel portfolio with an increasing mix of manachised and the franchised hotels.

As shown on Page 5, at the end of 2018 our manachised and the franchised hotel rooms accounted for 79% in total rooms in operation, further up by 1% from previous year. About 72% of these rooms are in Tier 1 and Tier 2 Cities, where we believe there are more sustainable demand for both business and leisure travel purpose and that's more resilient in performance. The asset-light model has also reduced our business volatility and helped Huazhu sail through changing economic environment.

Page 6, illustrates the relationship between our same-hotel RevPAR growth and our financial performance. The top chart shows the same-hotel RevPAR growth from 2011 to 2018. The RevPAR growth fluctuates between the low of negative 3.6% to a high of 7.7% during this period. However -- however, you may notice from the chart below that Huazhu continue to expand its EBITDA amount and largely, the margin percentage year-over-year during the same period despite the volatility of the RevPAR growth rate.

Huazhu is able to continue deliver solid financial performance on the various economic environment because we have been growing with an asset-light model as explained earlier with continuous focus on product innovations that meet the evolving needs of our customers and the franchise owners. Before we get into more details of operations and financials, I would like to take a few minutes to review, how we have fulfilled our strategic focus in 2018.

Page 7, shows the summary of our strategic achievements this year. The first focus is the fast expansion for midscale hotels. For 2018, our mid-and-upscale hotel room count increased by 42%, which accounted for 38% of total rooms in operation at the end of 2018. In addition to 1,338 (sic) mid-and-upscale hotels in operation, we have 831 mid-and-upscale hotels in pipeline. Such strong opening and pipeline growth consist of the contributions from mature brands like JI and Crystal Orange, as well as our younger brands like Mercure and HanTing Premium. By leveraging Huazhu's centralized operational platform and over 100 million member loyalty program, these younger brands are poised to take off.

Secondly, our focus on continuous growth in same-hotel RevPAR through quality improvements. In 2018, the same-hotel RevPAR increased by 5.5% with a 5.6% growth in the economy segment and a 5.2% growth in mid-and-upscale segment. Our efforts to upgrade HanTing hotels continued in 2018. As a result, the HanTing operated room ratio increased to 50% at the end of 2018, up from 38% in the prior year, and expect to exceed 60% by 2019.

Thirdly, our focus on innovation in Upscale Hotel segment. The acquisition of Blossom Hill in late 2018 expanded Huazhu's footprint for leisure hospitality. We're also excited about three prime locations signed under Joya brand. I'll elaborate the above points more in the following pages.

Let's turn to Page 8. On the first point, growth of midscale and the upscale hotels. As you can see, our staff expansion in this segment is well on track. By the end of 2018, our mid and upscale hotel rooms inventory increased by 42% from a year ago. As shown on the right hand side of the page, our pipeline for mid and upscale rooms accounted for approximately 80% of the total number of rooms in the pipeline, up from 77% a year ago. Our diversified mid and upscale hotel brand portfolio with profitable hotel operating models continue to attract potential franchisees into Huazhu's hotel network.

On Page 9, to help our investors to better understand our midscale brand and their respective development stage, we categorized these brands according to their scale and the city coverage. In the very next column, in stage I Debut, we have Mercure, HanTing Premium, Manxin and Novotel. Each has fewer than 100 hotels in operation and a coverage fewer than 50 cities, but moving rightward with strong pipeline. This relatively younger brands offer a very unique value proposition to our guests and franchisees.

Stage II Grow, between 100 to 500 hotels and covering 50 to 100 cities. Those brands categorized in the grow stage include Starway, Crystal Orange and Orange Select , Ibis and Ibis Styles combined. They are becoming our new growth (technical difficulty).

The Stage III Flourish represents hotel count of 500 to 2000 and a city coverage of 100 to 400. Thanks to great guest experience and a profitable operating model, JI hotel held 553 hotels in operations at the end of 2018 and 282 in pipeline. The strong growth momentum of JI will continue in 2019. We are optimistic about the industry prospects and the confidence in our quality brand to outperform competition.

In the long run, we anticipate that we will have multiple midscale brands to reach or exceed 2,000 hotels. It is defined as Stage IV Establish in our life cycle analysis. In addition, a few of our midscale brands will grow to over 500 hotels.

I would like to visualize the growth for two brands in the next few pages to help you get a flavor. First of all, JI brand. At the end of 2018, JI hotels covers 132 cities with more than 500 hotels. In 2018, JI brand registered 5% same-hotel RevPAR growth, a very strong momentum. Given JI brand's characteristic design and a superior profitability, we believe that JI brand will continue to accelerate its growth in years to come. The next milestone will be to hit 1,000 hotels and that's expected to be achieved in 2020.

The second example is Mercure. At the end of 2018, we have 39 Mercure hotels in operation and 69 in pipeline. In 2018, the same-hotel RevPAR for Mercure brand grew by 9.6%. In addition to a remarkable RevPAR performance, this brand has been fully integrated into Huazhu operating platform, which allow it to run with Huazhu's efficiency standard and to leverage Huazhu's loyalty program. For example, the staff-to-room ratio is currently at 0.2, represent a 40% saving in headcount and the personnel cost compared to its original model with the staff-to-room ratio of 0.35. We expect Mercure brands to hit its 100-hotel milestone next year.

As mentioned in the last two pages, we have a good progress in the midscale segment. As a result, the revenue contribution from our mid-and-upscale hotels has continued to increase. As shown on Page 12, in 2018, the revenue from mid-and-upscale hotels increased by 52% and account for 50% of total net revenues.

Turning to Page 13. our Q4 same-hotel RevPAR stood at 3.9% resulting in a 5.5% growth for the full year. After six quarters of phenomenal same-hotel RevPAR growth since Q1, 2017 partly due to a low comparable base. The third and the fourth quarter of 2018 reported same-hotel RevPAR growth of 4.2% and 3.9%, which we believe is healthy, and also it represents a more sustainable level of growth. The same-hotel RevPAR growth was mainly driven by ADR growth, as we continue to attract customers, while looking for product innovation to satisfy their needs.

On Page 14, similar to what we shared with you on previous calls, our quarterly occupancy remains at high level of 87% for mature hotels and 90% for the full year outperforming the China industry average by 20 percentage points relatively consistently. For the first two months in 2019, we continue to see a positive trend of same-hotel RevPAR growth.

Finally, please turn to Page 15. I'm pleased with our footprint into upscale resort brand by acquiring Blossom Hill in late 2018, positioned as an upscale lifestyle and resort brand, most of Blossom Hill's hotels are located in typical scenic spots. In 2019, we are going to showcase its new urban hotels at downtown landmark in Shanghai. We also decided to convert VUE Hotel in Beijing Hou Hai, center of the city into a Blossom Hill hotel. This include a conversion from VUE Hotel that will be done near -- near term. This hotel with 80 guest rooms is housed in a costly Historical building featuring a casual cafe, a splendid Spanish restaurant and a bar overseeing Hou Hai.

Last but not the least, heading into 2019, we will continue to focus on a few strategic aspects. As shown on Page 16, first, we will continue the fast expansion of our hotel network. Secondly, we will focus on the Innovative application of technologies to improve guest experience and operational efficiency. Third, we will make steady progress in Upscale Hotel segment. We expect to bring you more exciting news in the next earnings call.

With that, I will hand over the call to Teo, who will provide you a more detailed analysis on operational and financial results. Teo, please.

Nee Chuan Teo -- Chief Financial Officer

Thank you, Jenny. Good morning, everyone. Please turn to Page 18. We are thrilled to report that we continued with our fast expansion growth path in 2018. We opened two hotel every day with a total of 723 new openings in 2018. At the end of 2018, the total number of hotels in operation has reached 4,230. We have achieved a total gross openings of 723 hotels on a net of 484 hotels in 2018. The net openings of 484 hotels represent a 13% growth in hotel count. As Jenny mentioned earlier, we are confident to further accelerate our hotel expansion in 2019 given our increasing pipeline.

Turning to Page 19. In Q4, our Group blended RevPAR grew by 8.1%. This is mainly driven by an increase of ADR of 9.2% year-over-year. The increase in our blended RevPAR was driven by a 6.3% year-over-year increase in mature hotels RevPAR and the increasing mix of mid and upscale and upgraded hotels.

For the full year of 2018, our Group blended hotel RevPAR increased by 10%. The ADR increased by 11.2% and the increase was partially offset by a 1 percentage point decrease in occupancy. You may notice that the absolute level of our occupancy was very high at 87%. This 87% occupancy takes into account of all of our 4,200 hotels in total with 723 new hotels opened in 2018. A significant number of these newly opened hotels are recently completed and are still at the ramp-up stage with a lower occupancy.

Moving on to the financial results on Page 20. Our net revenues grew by 20.6% in Q4 and 22.3% for the full year of 2018, exceeding the high end of our previous guidance. Breaking down the revenue growth in 2018, the net revenues from our leased and operated hotels improved by 18%; and net revenue from our manachised and franchised hotels was up 37% year-over-year. In 2018, the net revenue contributed by our asset-light manachised business model accounted for 25.1% in total revenue, up 2.6 percentage points from 22.5% in 2017. We expect the contribution from the franchised business will continue to increase going forward.

As demonstrated on Page 21, we are referring to the box on the bottom left corner, the hotel operating costs and other operating costs, as percentage of the net revenues decreased by 4.7 percentage points year-over-year. This is mainly due to our improved blended RevPAR -- sorry, a better operating efficiencies from scales. In 2017, we booked impairment loss of RMB169 million in hotel operating costs and RMB35 million in 2018. Excluding the impact of this impairment loss in both 2017 and 2018, the hotel operating costs and other operating costs, as percentage of net revenues would have been reduced by 3 percentage points.

The pre-opening expenses as percentage of net revenues was 2.5% the same as last year. The SG&A expenses and other operating income, as percentage of net revenues decreased by 1.3 percentage points year-over-year. In 2018, there are certain one-time gains recorded in other operating income, such as compensation received and reversal of losses related to the termination of lease hotels totaling RMB130 million; and in 2017, such one-off amount was approximately RMB30 million (ph).

Our full year operating margin expanded by 6 percentage points year-over-year to 23.3%, driven mainly by better operating leverage and improved RevPAR, as well as hotel network expansion and certain one-off gains mentioned above. Excluding the above mentioned one-off gains in both 2017 and 2018, the operating margin would have been improved by 3.3 percentage point in 2018.

Turning to Page 22. In 2018, we record a strong growth in our core earnings driven by both strong RevPAR growth and a better operating leverage. The non-GAAP adjustment mentioned on this page, including the unrealized loss from the fair value changes of equity securities relating to our investment, such as Accor shares and (inaudible) totaling RMB914 million, as well as share-based compensation of RMB83 million in 2018. Excluding these non-GAAP adjustments in 2018, our adjusted EBITDA increased by 37% to RMB3.3 billion, while our EBITDA margin expanded from 28.9% to 32.5%. The adjusted net income increased 36% year-over-year to RMB1.7 billion. While the adjusted net income margin would have expanded from 15.3% to 17%.

Moving on to the cash flow status on Page 23. In 2018, we generated RMB3 billion of net cash from operations. After the capital expenditure on maintenance and new developments is totaling approximately RMB1.2 billion. The free cash flow generated in 2018 totaled RMB1.6 billion. In 2018, we draw down -- we drew down our US dollar syndication loan bank treaty and also raised a margin financing totaling RMB4.3 billion to finance the budget of Accor shares. We invested approximately RMB5.15 billion in total for the Accor shares, for the acquisition of Blossom Hill and some small investments in hotel-related funds. At the end of 2018, we had cash and cash equivalents of RMB4.9 billion.

Turning to Page 24. In 2018, we declared a cash dividend of US$100 million equivalent to US$0.34 -- 34 cent -- US$0.34 per share. This dividend is more than double than the 2017 dividend. Thanks to the tax planning arrangement, we were able to reduce the withholding tax on dividends, we thought (ph) that are out from China from 10% to 5%, thereabout we were able to double the dividend payment, while maintaining the withholding tax amount paid to the tax authorities. We expect to maintain the current level of dividend going forward.

Turning to Page 25. We will implement a new lease standard ASC 842 effective from January 1st, 2019. This will affect our lease, which are on a fixed payment basis with a term greater than 12 months. We estimate that the adoption of this standards will result in the recognition of right of use assets and lease liabilities of approximately US$2 billion to US$2.2 billion (ph) respectively, as of January 1st, 2019.

In the absence of any impairment, there would be no material change of any rent recognized in the income statement. However, given the materially higher right of use assets on our balance sheet, any lease impairment, if any, may be higher, which will negatively impact the operating profit in the year of impairment. Please note that the prior year results will not -- will not be restated with the impact -- impact of this accounting change, and therefore comparative periods remain as reported historically. Upon adoption of this accounting -- of this standard, we do not expect there -- any change in our cash flow statement.

Finally, our guidance on Page 26. In 2019, we plan to accelerate our gross opening to 800 hotels to 900 hotels, 75% of which are midscale-and-upscale hotels. For the revenue guidance, we expect to achieve a net revenue growth rate of 13% to 15% in Q1, 2019. For the full year in 2019, we expect a net revenue growth of 15% to 17%.

With that let's open the call for questions.

Ida Yu -- Investor Relations Manager

Operator, we are ready to take any questions from the investors.

Questions and Answers:

Operator

Thank you. Ladies and gentlemen, we will now begin the question-and-answer session. (Operator Instructions) There are currently no questions at this time. I'll now let's hand the conference back to today's presenters. Please continue.

Min Zhang -- Chief Executive Officer

Operator, we have been noticed that some of the analysts actually pressed, but maybe the system is not working. Can you check?

Operator

Yes. All right. So the first question is from the line of Justin Kwok. Your line is now open.

Justin Kwok -- Goldman Sachs -- Analyst

Hi, thanks for taking my question. Perhaps I'll -- I'll shoot in two question, one on the growth guidance; and the other one on margins. So I think you have a very good finish on 2018 and now your full year guidance is 15% to 17% on the net revenue growth. Can I check? What kind of RevPAR assumption you're baking into this set of forecast?

And on the other hand, have you been baking in the focus for the development or the grooming up of the soft brands, which you have probably announced back in the December -- Huazhu conference anyway (ph) so whether the soft brands would start to kick in any meaningful or small impact in 2019?

The second question on margins is that now in 2018, you got faster rapid growth and also some lower base effect on the G&A because of these long-term share based compensation booking. Into 2019, would there any guidance on the margins outlook moving forward? Thank you.

Nee Chuan Teo -- Chief Financial Officer

Hi, Justin this is Teo. Regarding the growth assumptions, we -- right now, we built in approximately 3% growth in the same-hotel RevPAR, and we have not built in the -- the revenue from our soft brand yet, as the main reason is because that we are still in incubating stage, and we had to -- we had to see that how -- how quickly can we grow this business.

On the second question -- second question is on the margin, we expect that the -- the hotel business will continue to generate a certain amount of margin expansion. However, as mentioned in the last quarter calls, as well as, we'll actually continue to invest some of the margin expansion to build some of the new business, as well as the our software -- as well as the soft brand. In addition, we'll also, as mentioned by Jenny earlier, we'll put in some money, we also invest in some of the experimentations on the upscale brand, so that may insulate some of the -- our margin expansions.

Justin Kwok -- Goldman Sachs -- Analyst

All right. Thanks. Any color on the progress of the soft brand as a follow-up? Thanks.

Min Zhang -- Chief Executive Officer

Yeah. We have deployed a concentrated development team to accelerate the growth of our soft brands. Most of the brands are existing brands that are already in the market for a few years, such as Starway, Elan, Hi Inn. We are also going to launch new brand called Madison in the next couple of weeks, which is going to accelerate our growth in the Upscale segment, In generally (ph) speaking, we are happy with the launch of the expansion acceleration program yet because we are still in the early stage, we don't want to provide unreliable prediction about how much revenue they are going to generate within this year. We will keep you guys updated in our next earnings call.

Justin Kwok -- Goldman Sachs -- Analyst

Thank you.

Operator

Thank you. The next question we have is from the line of Praveen Choudhary. Your line is now open.

Praveen Choudhary -- Morgan Stanley -- Analyst

Thank you. Thanks for taking my call. Hi, Jenny. Hi, Mr. Teo. Very quick question from me. You mentioned about the full year guidance of 15% to 17% revenue growth, it's baking around 3% like-for-like RevPAR growth. Considering Q1 revenue growth is smaller 13% to 15%, is that because your RevPAR assumption for Q1 is much less as in 1% to 2%? Or is it just a function of less number of new openings?

Nee Chuan Teo -- Chief Financial Officer

Okay. The reason why we think that we -- we built in the 13% to 15% obviously because that there was -- number one is that -- that last year, the -- due to the timing of the Chinese New Year is that -- that is actually a high base in the Q1 last year. In addition to that is that we -- from the trend that we see right now, we see that the -- the traffic has been picking up after the Chinese New Year. So we would like to -- we think that the -- the momentum will actually bring in higher revenue growth in -- in the coming quarters. Plus that you may -- actually you may already know is that Q1 is the most volatile season because the -- the traffic has been low -- is the lowest in -- in a entire year. So we -- we would like to built in the -- this assumption, so that we will see how it goes in the next couple of quarters.

Praveen Choudhary -- Morgan Stanley -- Analyst

Okay. Got it. Thank you. Can I also ask that in Q1 of '19, Crystal Orange will be part of like-for-like RevPAR. And the second related question is, when you give us like-for-like RevPAR for full year 3%, what could be the -- what could be the total RevPAR growth. For example, in Q4, you had RevPAR increase of 8.1% versus the same-store sales of 3.9%, so there's a gap because of the mix improvement, right? Just trying to understand, if there was any guidance on the full year number for the total RevPAR not just like-for-like in your growth assumption?

Nee Chuan Teo -- Chief Financial Officer

The blended RevPAR is usually like 3% -- right around 3% -- 3% to 4% increase higher than the same-hotel RevPAR growth. As you -- as you rightly mentioned, this is mainly due to the mix change.

Praveen Choudhary -- Morgan Stanley -- Analyst

And Q1, would you be putting like-for-like -- it's Crystal Orange inside like-for-like ?

Nee Chuan Teo -- Chief Financial Officer

Right. Definitely. Yeah. We will -- we will include the Crystal Orange hotels in like-for-like in Q1.

Praveen Choudhary -- Morgan Stanley -- Analyst

Okay, great. Maybe one last question from me if I can. This whole RevPAR improvement is because of the mix, market wanted to -- our investors wants to understand how long this mix improvement can last. I mean, clearly your pipeline is very much skewed toward midscale. Can you talk about this supply demand scenario in midscale? And if the economy slowdown that we saw in fourth quarter and up to Chinese New Year impacts your midscale supply, demand, occupancy or any such thing? Thank, you.

Min Zhang -- Chief Executive Officer

I think the mix shift will continue. Number one, we are still growing our midscale business very fast. Secondly, even within the midscale, you know, we are accelerating the growth of the upper midscale part of the business. Certainly, we are also putting more efforts into the growth of our upscale business. So all those factors are going to continue, and we expect a long runway for our blended RevPAR growth to continue.

Praveen Choudhary -- Morgan Stanley -- Analyst

Very helpful, Jenny. And again, thank you and congratulations for great set of results.

Min Zhang -- Chief Executive Officer

Thank you.

Operator

Thank you. The next question we have is from the line of Mr. Alan Dang (ph) from CARA (ph). Your line is now open, sir.

Alan Dang -- CARA -- Analyst

Yeah. Hi, thank you. Thank you management for -- for the call and vision. And can I ask you -- on the follow-up on the first quarter assumption. What have you seen for January and February RevPAR growth are same for like-for-like and the blended RevPAR?

And can I also understand that you have mentioned in that you had -- you'll see some -- there is some margin leverage for the hotel business, but put more investment into soft brands and new brands. And would that be -- would that mean that the brand -- the margin for -- blended margin for this year will not expand as much as last year or will -- actually, you will invest on the margin expansion for the investment? Thank you.

Nee Chuan Teo -- Chief Financial Officer

Hi, Alan, let me answer your first question. First in the January and February is that we are still growing on a same-hotel RevPAR growth basis that we are still in a positive territory in the low single digits. But on your following questions, can you repeat that, perhaps one question at a time.

Alan Dang -- CARA -- Analyst

Yeah. So the margin, you -- you mentioned there'll be some margin expansion still for the hotel business, and you'll put more investment into new brand, the soft brands recognition (ph). And as the end result, will we still see margin expansion overall for the Company? Or are we going to see a flat margin more likely for 2019?

Nee Chuan Teo -- Chief Financial Officer

Okay. On this question is that we expect the margin expansion to continue, and then we will spend some money in -- investing in not only the soft brands, but also the new -- some of the new business, as well as on the -- the upscale hotels. We expect that the impact of that, I think very uncertain because we -- we are still at a very early stage on how exactly -- how much money we would need to spend on these investments. So we would see supporting that in the coming quarters.

Alan Dang -- CARA -- Analyst

Sure. Thank you. Another follow-up question on the new hotel openings. Given this -- the macro economy is weaker and then would that impact your hotel openings quite especially the franchisees, the willingness of opening new hotels?

Min Zhang -- Chief Executive Officer

Well, so far, the signing and opening are well on track. And when we look at our business by segment, we see the majority of our business, especially economy hotels and our core and midscale brands actually performed quite strongly in today's (ph) economic environment. So we don't expect the signing and the opening of new hotels will experience any major slowdown.

Alan Dang -- CARA -- Analyst

Okay. Thank you.

Operator

Thank you. The next question we have is from the line of Mr. Billy Ng from Bank of America. Your line is now open, sir.

Billy Ng -- Bank of America -- Analyst

Hi, good morning and congratulations on a very strong set of results. I have two questions. One is, can you give us a little bit more color because when we look at the STR data, January was kind of weak probably because of the timing of Chinese New Year, but it's -- can you provide a little bit more color, what happened after Chinese New Year's and what kind of same-store RevPAR we are seeing roughly speaking in the last few weeks?

And my second question is just can you provide any color or outlook of the M&A market right now. Like in 2019, we looked at some of the public equities, multiple has compressed, but would that become a bit easier or is -- is still quite challenging to find new opportunities within China at this point?

Min Zhang -- Chief Executive Officer

This is Jenny. On the question about the recent performance trend, we have seen January and February combined, we continue to see positive growth of the same-hotel RevPAR, which we believe in today's economic environment, this is a positive indicator. We will discuss the performance in more detail when it comes to our quarterly end disclosure.

And on acquisitions, you know, as you have seen, we have been a active rather cautious acquirer of various brands to reach our strategic goal of creating a strong and full range brand portfolio. So we will continue actively looking into various opportunities, but take a very rational perspective in doing those deals.

Billy Ng -- Bank of America -- Analyst

Thank you.

Operator

Thank you. The next question we have is from the line of Mr. Dylan Chu from CLSA. Your line is now open.

Dylan Chu -- CLSA -- Analyst

Thanks, management for the presentation and congratulations on the good result, good '18. I've got couple of questions, so I'll ask one by one. Firstly, which is in terms of manachised and franchised effective take rate, thanks for sort of disclosing the turnover metric. If my calculations are right, it seems like 4Q, '18 effective take rate on manachised and franchised operations increased both sequentially and on a year-over-year basis. Could you please share some color just in terms of the drivers? Should we consider this sort of signal or actually sustainable? And any sort of guidance on sort of take rate going forward into this year would be very helpful.

Nee Chuan Teo -- Chief Financial Officer

Okay. The take rate -- the effective take rate from the manachised and franchised business has actually gone up -- ticked up a little bit. This is what you observe is correct. This is actually mainly driven by the increasing contributions from the -- our centralized reservation systems. It means that the -- the customer that we push through to -- to our franchisees, so because we charge a percentage based on that -- the traffic that we charge to the franchisees. So the increasing traffic to the franchisees are from our centralized reservation systems will actually contribute positively to our take rate. And we -- it's also our continuous effort to increase the percentage of room night that is contributed by our -- from a direct sales channel. So we -- we hope that this trend will continue, and then is that we will continue to -- to have a higher take rate going forward.

Dylan Chu -- CLSA -- Analyst

Thank you, Teo. That's very helpful. Secondly, just in terms of historical costs, last quarters costs, hotel operating expenses were actually a very strong outcome overall. Could you please just give us a little bit more color in terms of driver of that very strong cost control. And specifically why other hotel operating expenses actually declined -- declined about RMB200 million last quarter -- last year to about RMB150 million despite quite strong revenue outcome. Just any color in terms of costs, would be very helpful.

Nee Chuan Teo -- Chief Financial Officer

Okay. The -- the hotel operating costs, as percentage of revenue has declined, as I mentioned earlier. The main reason -- there are -- there are two -- two main reason behind that. Number one is that the -- we actually run a better operating leverage without increasing number of scales, as well as the increasing contribution from the manachised and franchised business is number one.

And number two, I -- as mentioned earlier in my presentation is that in 2017, there is actually impairment loss of RMB169 million that was recorded in hotel operating costs added, whereas this -- in this year, in 2018, the impairment loss recorded in this line is only RMB35 million. So there is actually a drop of around RMB130 million due to that. So the -- the lower operating costs, as percentage of revenue, it -- it was helped by the reduction in the impairment loss recorded.

Dylan Chu -- CLSA -- Analyst

Great. Thanks. Just question number three, just in terms of openings and quite strong guidance. Just related to this, could you please share and update in terms of CapEx and dividend for 2019, please?

Nee Chuan Teo -- Chief Financial Officer

Okay. Our capital expenditure, we expect to increase our capital expenditure to -- I would say that coming to around RMB1.9 billion -- RMB1.9 billion to RMB2 billion in 2019. The main reason is because number one is that our -- our new hotel capital expenditure is expected to be approximately RMB1.2 billion; and then is that our repair -- our maintenance and upgrade will be approximately RMB400 million. And we will spend -- we would -- we're actually budgeted to spend approximately RMB200 million, as part of the payment for our headquarters, our construction costs.

Dylan Chu -- CLSA -- Analyst

Thanks. Just last question, just sort of operationally. Our -- the hotel pipeline has reached a historical height as well. Just sort of, what sort of the capacity utilization rate of our sort of development team, let's say by end of this year, the pipeline were to increase toward maybe, 1,300 or 1,500, will we need to increase headcount (ph) or sort of our current capability is already enough?

Nee Chuan Teo -- Chief Financial Officer

Okay. Now, I suppose is that you may see that the result of the higher pipeline this year, it was actually our investment in some of the development team that we started off last year. And in the Q2, there was a question of why there was an increase in the G&A expenses, and this is a result of which -- of which. So in fact -- that are (ph) -- this is no. So what we have been seeing is that the productivity from our development team has not been fully released yet. So there may be some benefit in terms of like increasing pipelines from our existing team. However, is that if you go beyond a certain stage, then we may need to increase the -- our development teams further.

Dylan Chu -- CLSA -- Analyst

Yeah, yeah. I understand sir. So I guess my question would be, just given our investments last year around second quarter, so -- so they still have some actual capacity?

Nee Chuan Teo -- Chief Financial Officer

I'm sorry. Can you repeat your question?

Dylan Chu -- CLSA -- Analyst

So yeah I think I got your question -- I got your answer. So -- so that's all from my side. Thanks very much.

Nee Chuan Teo -- Chief Financial Officer

Thank you.

Operator

Thank you. We have the next question from the line of Aras Poon from Citigroup. You may now ask your question.

Aras Poon -- Citigroup -- Analyst

Good morning, management. This is Aras from Citi. So thanks for taking my question. Perhaps can you give us a little bit more colors in terms of the operating trends that you see in Tier 1 and 2 cities and also the lower tier cities? I mean, you have a very strong portfolios in Tier 1 and Tier 2 cities, but given the Company's continue to expand and increase your hotel counts, we are -- should we expect you gradually have more exposures in the lower tiers. So would like to get a sense of how do you see the growth opportunity there and how do you see the trends there? When you say 3% like-to-like RevPAR growth that you are looking for. Do you see a huge difference between the higher tier cities and the lower tier cities? Thank You.

Min Zhang -- Chief Executive Officer

We actually see growth opportunities across all tiers of cities, from Tier 1 to Tier 3. So we are actually going to deploy our development teams to capture the full range of the opportunities. Currently, we don't have a deep penetration into the Tier 3 cities yet, but we see few of our mature brands, such as HanTing, JI hotel, plus with a few others actually have demonstrated strong business case in Tier 3 cities, which give us the confidence to accelerate the growth in those markets. And in terms of the upscale hotels, we also feel, there are demand across all tiers.

Aras Poon -- Citigroup -- Analyst

Do you see the RevPAR trends are fairly different in -- in the higher tier cities and the lower tier cities?

Min Zhang -- Chief Executive Officer

Actually, it's not -- it's little bit difficult to categorize by tier because China's economy has been growing unevenly from region to region. For example, you know, even in Tier 1 cities, Beijing in the recent couple of years has been continuously very strong, but the Shanghai may experience a little bit more fluctuation depending on how the exhibition activities going on from year-to-year. So it's a little bit difficult to just generalize by tier of cities. It's more relevant to think about this region-by-region or city-by-city.

Aras Poon -- Citigroup -- Analyst

Okay. That's very helpful. Thank you.

Operator

Thank you. And we have the next question from the line of Lina Yan from HSBC. You may now ask your questions.

Lina Yan -- HSBC -- Analyst

Hi, management, thanks very much for taking my questions. My first question is regarding your pipeline. You have reached a peak pipeline in 2018. And my question is, do you think this pipeline will continue to grow, maybe you can give us some color from a top down point of view. For example, like for the growing market, midscale-and-upscale, how do you think the market can grow into -- like in terms of total number of midscale-and-upscale hotels. And what's your market share in this market segment?

And then for the more mature economic -- like limited service hotel segment, what do you think the market share consolidation opportunity will help you grow your pipeline in the future? And also like related to the discussion on city tier like exposure. If you talk about a potential growth in pipeline, what kind of opportunity, do we see in Tier 3 cities? And do you still have expansion opportunities in the big four cities? That's my first question.

Min Zhang -- Chief Executive Officer

We have seen -- we have actually conducted a survey recently to understand what kind of market share we are having in China. And according to gross market value, you know, we are only somewhere between 3% to 4% of the total China hotel market (technical difficulty) sort of look into. So number one, we feel we have a lot of room for market share gain in China. And secondly, if you break down into the city-by-city data, we will see the consolidated level of cities varies, but are generally low.

You can see for Tier 3 cities, most of the cities at consolidation level is less than 10%, and the Tier 1 cities are also only between 10% to 25%. So this kind of consolidation level also represents across -- opportunities, you know, across the different tiers of cities. So with that, you know, we believe with our increased efforts and the investment into the development team, we will continue to see our pipeline and opening to grow in the coming few years.

Lina Yan -- HSBC -- Analyst

Okay. That's very helpful. But just a follow-up like for midscale-and-upscale like in three years time, do you think what's the market capacity for that like a total number of midscale-and-upscale limited service hotels?

Min Zhang -- Chief Executive Officer

As you can see in our pipeline, we are going to open a significant number of midscale-and-up hotel -- upscale hotels each year. This year, I believe for midscale-and-upscale alone, we are going to open more than 700 hotel.

Lina Yan -- HSBC -- Analyst

Okay. Thank you very much. And I also have a second question like upgrade is also a very important driver for your overall portfolio. Can you give us the guidance and the progress of upgrade? And what kind of like upgrade are we expecting this year?

Min Zhang -- Chief Executive Officer

As you have seen, we have increased the rental leases (ph) or new product ratio for HanTing to 50% by the end of last year. And we expect to grow it further into 60% by the end of this year. This trend will continue into the next few years.

Lina Yan -- HSBC -- Analyst

Okay. Thank you. But like for this upgrade, we'll -- will we see a structural change like is the upgrade to HanTing 3.0 or even to like a higher -- like a midscale like a kind of upgrade, is there like a further shift in this upgrade?

Min Zhang -- Chief Executive Officer

Most of the HanTing will be upgraded into HanTing new version or HanTing Premium within the same brand portfolio. A small percentage of the upgrade will change HanTing into JI Hotel.

Lina Yan -- HSBC -- Analyst

Okay. Thank you very much. And I have a like last question is on the pipeline. Can you give us more like details on the gross opening. What's the breakdown between owned and leased and franchised and managed. And for closure, what is the breakdown between these two business models? Thank you.

Nee Chuan Teo -- Chief Financial Officer

Sorry. Can you repeat the questions?

Lina Yan -- HSBC -- Analyst

So for 2019 gross opening guidance and closure guidance, what is the breakdown by business models, owned and leased and franchised and managed? Or like what's the gross opening for owned and leased and closure for owned and leased?

Nee Chuan Teo -- Chief Financial Officer

Yes. Our gross opening, we expect to be at 800 hotels to 900 hotels, of which approximately like 40 hotels to 50 hotels will be leased and operated. Whereas for closures is that, we plan to close approximately in the -- in a range of around 200 hotels, maybe in the range of maybe 20 hotels to 25 hotels -- 20 hotels to 30 hotels will be leased and operated.

Lina Yan -- HSBC -- Analyst

Okay. Thank you. Thank you. And would it be possible for you to share with us, what is the same-store RevPAR growth in December last year? And that's my last question. Thank you very much.

Nee Chuan Teo -- Chief Financial Officer

I'm sorry, because the same-hotel RevPAR -- there -- there is statistics of same-hotel RevPAR growth in the 6-K.

Lina Yan -- HSBC -- Analyst

Okay. Thank you.

Operator

Thank you. I would now like to hand the conference back to today's presenters, please continue.

Min Zhang -- Chief Executive Officer

Thank you. Thank you, everyone for taking time today, and we look forward to talking to you in the next earnings call. Bye-bye.

Operator

Ladies and gentlemen, that does conclude our conference for today. Thank you for participating. You may now disconnect.

Duration: 61 minutes

Call participants:

Ida Yu -- Investor Relations Manager

Min Zhang -- Chief Executive Officer

Nee Chuan Teo -- Chief Financial Officer

Justin Kwok -- Goldman Sachs -- Analyst

Praveen Choudhary -- Morgan Stanley -- Analyst

Alan Dang -- CARA -- Analyst

Billy Ng -- Bank of America -- Analyst

Dylan Chu -- CLSA -- Analyst

Aras Poon -- Citigroup -- Analyst

Lina Yan -- HSBC -- Analyst

More HTHT analysis

Transcript powered by AlphaStreet

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

Friday, March 15, 2019

Top 10 Small Cap Stocks To Buy For 2019

tags:CNR,ATAI,MOBI,ACHN,PQ,FCEL,

U.S. equities are back in negative territory on Monday after suffering four straight days of losses during last week’s holiday-shortened run. Technology stocks are trying to rally, but they are being thwarted by ongoing trade concerns with China as President Trump has threatened a third round of tariffs on nearly $300 billion worth of imports, following a second round of tariffs on roughly $200 billion in imports.

The latest is that Chinese officials are hoping Democrats carry the day in November’s mid-term elections (and thus, thwart Trump’s trade agenda) or that Wall Street officials will ratchet up the pressure. Both are far from assured. Moreover, investors continue to fret about Friday’s hotter-than-expected wage data which increases the chances of a more aggressive rate hike pace from the Federal Reserve.

As a result, the Russell 2000 small cap index is threatening to fall below its 20-day moving average for the first time in weeks after extending to new record highs throughout the end of August. Smaller stocks have been lagging their large-cap peers since the end of June, as investors pile into mega-cap technology names like Amazon (NASDAQ:AMZN) and Apple (NASDAQ:AAPL).

Top 10 Small Cap Stocks To Buy For 2019: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:
  • [By Shane Hupp]

    Shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) have been assigned a consensus recommendation of “Buy” from the twenty-two ratings firms that are currently covering the firm, Marketbeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $91.71.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its stake in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 842,775 shares of the transportation company’s stock after selling 13,507 shares during the quarter. State of Tennessee Treasury Department owned about 0.11% of Canadian National Railway worth $61,565,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    Several brokerages have updated their recommendations and price targets on shares of Canadian National Railway (TSE: CNR) in the last few weeks:

    2/11/2019 – Canadian National Railway was given a new C$117.00 price target on by analysts at Morgan Stanley. 1/31/2019 – Canadian National Railway was given a new C$116.00 price target on by analysts at BMO Capital Markets. They now have a “market perform” rating on the stock. 1/30/2019 – Canadian National Railway had its “outperform” rating reaffirmed by analysts at Raymond James. They now have a C$125.00 price target on the stock. 1/30/2019 – Canadian National Railway had its price target raised by analysts at TD Securities from C$125.00 to C$130.00. They now have a “buy” rating on the stock. 1/30/2019 – Canadian National Railway had its price target raised by analysts at CIBC from C$118.00 to C$119.00. 1/30/2019 – Canadian National Railway had its price target raised by analysts at JPMorgan Chase & Co. from C$116.00 to C$119.00. 1/14/2019 – Canadian National Railway had its price target raised by analysts at JPMorgan Chase & Co. from C$112.00 to C$116.00. 1/7/2019 – Canadian National Railway had its price target raised by analysts at Morgan Stanley from C$114.00 to C$115.00. 1/2/2019 – Canadian National Railway had its price target lowered by analysts at CIBC from C$120.00 to C$118.00. 12/19/2018 – Canadian National Railway had its price target lowered by analysts at National Bank Financial from C$119.00 to C$110.00. They now have a “sector perform” rating on the stock. 12/18/2018 – Canadian National Railway had its price target lowered by analysts at JPMorgan Chase & Co. from C$122.00 to C$112.00. 12/17/2018 – Canadian National Railway had its price target lowered by analysts at Royal Bank of Canada from C$130.00 to C$128.00.

    Shares of CNR stock traded up C$1.79 during tr

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

Top 10 Small Cap Stocks To Buy For 2019: ATA Inc.(ATAI)

Advisors' Opinion:
  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 10 Small Cap Stocks To Buy For 2019: Sky-mobi Limited(MOBI)

Advisors' Opinion:
  • [By Ethan Ryder]

    Mobius (CURRENCY:MOBI) traded 1.2% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on August 21st. In the last week, Mobius has traded down 1.1% against the dollar. One Mobius token can now be bought for about $0.0291 or 0.00000452 BTC on popular cryptocurrency exchanges including GOPAX, BitMart, Gate.io and Stellar Decentralized Exchange. Mobius has a total market capitalization of $11.23 million and approximately $78,528.00 worth of Mobius was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded up 0.1% against the dollar during the 24 hour period ending at 18:00 PM ET on February 11th. In the last week, Mobius has traded 3.1% lower against the dollar. One Mobius token can now be bought for approximately $0.0095 or 0.00000260 BTC on exchanges including OTCBTC, Gate.io, Stellar Decentralized Exchange and BitMart. Mobius has a total market capitalization of $4.89 million and approximately $19,445.00 worth of Mobius was traded on exchanges in the last day.

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded 12.4% lower against the US dollar during the 24 hour period ending at 17:00 PM E.T. on September 25th. One Mobius token can now be bought for approximately $0.0265 or 0.00000414 BTC on major cryptocurrency exchanges including Gate.io, Kucoin, BitMart and GOPAX. Over the last week, Mobius has traded up 8.8% against the US dollar. Mobius has a market cap of $10.22 million and approximately $69,762.00 worth of Mobius was traded on exchanges in the last day.

  • [By Logan Wallace]

    Media coverage about Sky-mobi (NASDAQ:MOBI) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sky-mobi earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.6853785900783 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Small Cap Stocks To Buy For 2019: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    BidaskClub upgraded shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a strong sell rating to a sell rating in a research report sent to investors on Tuesday morning.

  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

Top 10 Small Cap Stocks To Buy For 2019: Petroquest Energy Inc(PQ)

Advisors' Opinion:
  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Small Cap Stocks To Buy For 2019: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:
  • [By Scott Levine]

    One of the notable advantages of fuel cells is that they produce very little pollution. FuelCell Energy (NASDAQ:FCEL), however, believes that it could leverage the power of fuel cells in another way to fight pollution -- by capturing it. Partnering with ExxonMobil and Southern Company, FuelCell Energy is developing a carbon-capture solution to be used at gas-fired power plants. The pilot project is under development at a power plant in Alabama.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 4% in short interest during the period. Some 7.42 million shares were short as of June 15. The stock closed at $1.37 on Tuesday, down about 1.4% for the day, in a 52-week range of $1.18 to $2.49. Shares traded down more than 10% in the short interest period, and days to cover dropped from 17 to six.

  • [By Logan Wallace]

    FuelCell Energy Inc (NASDAQ:FCEL) has earned an average rating of “Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $3.80.

  • [By Peter Graham]

    Small cap fuel cell stock FuelCell Energy Inc (NASDAQ: FCEL) reported Q4 and fiscal year ended October 31, 2017 earnings with Q4 total revenues being $47.9 million versus $24.5 million:    

Thursday, March 14, 2019

$452.37 Million in Sales Expected for Jazz Pharmaceuticals PLC (JAZZ) This Quarter

Wall Street brokerages forecast that Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) will report sales of $452.37 million for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Jazz Pharmaceuticals’ earnings. The lowest sales estimate is $435.50 million and the highest is $461.60 million. Jazz Pharmaceuticals reported sales of $444.61 million during the same quarter last year, which indicates a positive year over year growth rate of 1.7%. The business is scheduled to report its next earnings report on Tuesday, May 14th.

On average, analysts expect that Jazz Pharmaceuticals will report full year sales of $2.03 billion for the current year, with estimates ranging from $1.95 billion to $2.11 billion. For the next year, analysts forecast that the company will report sales of $2.30 billion, with estimates ranging from $2.21 billion to $2.41 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that follow Jazz Pharmaceuticals.

Get Jazz Pharmaceuticals alerts:

Jazz Pharmaceuticals (NASDAQ:JAZZ) last posted its quarterly earnings data on Tuesday, February 26th. The specialty pharmaceutical company reported $3.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.66 by $0.98. The company had revenue of $476.46 million for the quarter, compared to analyst estimates of $459.48 million. Jazz Pharmaceuticals had a net margin of 28.09% and a return on equity of 24.92%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm posted $2.95 earnings per share.

JAZZ has been the subject of a number of recent analyst reports. Oppenheimer set a $180.00 price target on shares of Jazz Pharmaceuticals and gave the stock a “buy” rating in a research report on Sunday, December 23rd. Cantor Fitzgerald reissued a “buy” rating and set a $185.00 price target on shares of Jazz Pharmaceuticals in a research report on Tuesday, February 12th. Wells Fargo & Co reissued a “buy” rating on shares of Jazz Pharmaceuticals in a research report on Sunday, December 23rd. BidaskClub raised shares of Jazz Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Tuesday, December 18th. Finally, Wolfe Research initiated coverage on shares of Jazz Pharmaceuticals in a research report on Friday, December 14th. They set a “peer perform” rating for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have assigned a buy rating to the company. Jazz Pharmaceuticals currently has a consensus rating of “Buy” and a consensus target price of $188.56.

In other Jazz Pharmaceuticals news, SVP Paul Treacy sold 874 shares of Jazz Pharmaceuticals stock in a transaction on Friday, March 1st. The shares were sold at an average price of $139.50, for a total value of $121,923.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Suzanne Sawochka Hooper sold 3,334 shares of Jazz Pharmaceuticals stock in a transaction on Friday, December 14th. The stock was sold at an average price of $140.21, for a total transaction of $467,460.14. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,002 shares of company stock valued at $2,074,027. 3.90% of the stock is currently owned by corporate insiders.

Institutional investors have recently added to or reduced their stakes in the business. Enlightenment Research LLC acquired a new position in Jazz Pharmaceuticals in the fourth quarter worth $37,000. First Hawaiian Bank boosted its holdings in Jazz Pharmaceuticals by 42.2% in the fourth quarter. First Hawaiian Bank now owns 320 shares of the specialty pharmaceutical company’s stock worth $39,000 after purchasing an additional 95 shares during the period. Legacy Financial Advisors Inc. acquired a new position in Jazz Pharmaceuticals in the fourth quarter worth $56,000. Stratos Wealth Partners LTD. acquired a new position in shares of Jazz Pharmaceuticals during the third quarter valued at $106,000. Finally, Riverhead Capital Management LLC acquired a new position in shares of Jazz Pharmaceuticals during the third quarter valued at $113,000. 91.97% of the stock is owned by hedge funds and other institutional investors.

Shares of JAZZ traded up $0.48 during mid-day trading on Wednesday, reaching $133.00. 575,783 shares of the stock traded hands, compared to its average volume of 710,468. Jazz Pharmaceuticals has a 12-month low of $113.52 and a 12-month high of $184.00. The company has a quick ratio of 4.16, a current ratio of 4.29 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $7.99 billion, a P/E ratio of 10.87, a P/E/G ratio of 0.88 and a beta of 1.17.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.

Further Reading: Growth Stocks, What They Are, What They Are Not

Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Tuesday, March 12, 2019

Ashtead Group plc (AHT) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of Ashtead Group plc (LON:AHT) have earned an average recommendation of “Buy” from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is GBX 2,312.50 ($30.22).

Several equities analysts have issued reports on the stock. Liberum Capital restated a “buy” rating on shares of Ashtead Group in a research note on Monday, January 14th. Numis Securities restated a “buy” rating and set a GBX 2,800 ($36.59) target price on shares of Ashtead Group in a research note on Tuesday. Deutsche Bank restated a “hold” rating on shares of Ashtead Group in a research note on Wednesday, December 12th. UBS Group restated a “sell” rating and set a GBX 1,700 ($22.21) target price on shares of Ashtead Group in a research note on Thursday, November 29th. Finally, Peel Hunt restated a “buy” rating on shares of Ashtead Group in a research note on Thursday, January 3rd.

Get Ashtead Group alerts:

Ashtead Group stock traded down GBX 80 ($1.05) during mid-day trading on Friday, reaching GBX 1,897 ($24.79). The stock had a trading volume of 2,337,312 shares, compared to its average volume of 2,210,000. Ashtead Group has a one year low of GBX 1,476 ($19.29) and a one year high of GBX 2,185 ($28.55).

Ashtead Group (LON:AHT) last announced its quarterly earnings results on Tuesday, March 5th. The company reported GBX 40 ($0.52) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of GBX 39.90 ($0.52) by GBX 0.10 ($0.00).

About Ashtead Group

Ashtead Group plc, together with its subsidiaries, rents a range of construction and industrial equipment. It offers equipment for use in lifting, powering, generation, moving, digging, compacting, drilling, supporting, scrubbing, pumping, directing, heating, and ventilating works. The company provides various types of construction equipment for non-residential construction markets; and facilities management equipment for the maintenance and repair of facilities.

Featured Article: How is the S&P 500 index different from the DJIA?

Analyst Recommendations for Ashtead Group (LON:AHT)

Sunday, March 10, 2019

Catalyst Biosciences Inc (CBIO) Files 10-K for the Fiscal Year Ended on December 31, 2018

Catalyst Biosciences Inc (NASDAQ:CBIO) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is engaged in creating and developing novel medicines to address serious medical conditions. Catalyst Biosciences Inc has a market cap of $93.880 million; its shares were traded at around $7.86 with and P/S ratio of 110.75. Catalyst Biosciences Inc had annual average EBITDA growth of 33.50% over the past five years.

For the latest fiscal year the company reported a revenue of $0.01 million, a decrease of 99.4% from the previous year. For the last five years Catalyst Biosciences Inc had an average revenue decline of 51.8% a year.

The reported loss per diluted share was $2.68 for the year, compared with the loss per share of $269.849 in the previous year. The Catalyst Biosciences Inc had an operating margin of -563700%, compared with the operating margin of -2143.61% a year before. The 10-year historical median operating margin of Catalyst Biosciences Inc is -287.54%. The profitability rank of the company is 1 (out of 10).

At the end of the fiscal year, Catalyst Biosciences Inc has the cash and cash equivalents of $31.2 million, compared with $14.5 million in the previous year. The company had no long term debt. Catalyst Biosciences Inc has a financial strength rank of 8 (out of 10).

At the current stock price of $7.86, Catalyst Biosciences Inc is traded at 976.7% premium to its historical median P/S valuation band of $0.73. The P/S ratio of the stock is 110.75, while the historical median P/S ratio is 10.28. The stock lost 72.25% during the past 12 months.

For the complete 20-year historical financial data of CBIO, click here.

Saturday, March 9, 2019

Lafargeholcim (LHN) Given a CHF 55 Price Target by JPMorgan Chase & Co. Analysts

JPMorgan Chase & Co. set a CHF 55 price target on Lafargeholcim (VTX:LHN) in a research note published on Monday. The brokerage currently has a buy rating on the stock.

Several other brokerages have also weighed in on LHN. UBS Group set a CHF 47 price objective on Lafargeholcim and gave the stock a neutral rating in a report on Thursday, November 22nd. Morgan Stanley set a CHF 58 price objective on Lafargeholcim and gave the stock a buy rating in a report on Wednesday, November 14th. Goldman Sachs Group set a CHF 51 price objective on Lafargeholcim and gave the stock a neutral rating in a report on Tuesday, November 13th. Sanford C. Bernstein set a CHF 63.60 price objective on Lafargeholcim and gave the stock a buy rating in a report on Tuesday, November 13th. Finally, HSBC set a CHF 44 price objective on Lafargeholcim and gave the stock a neutral rating in a report on Monday, February 4th. Five analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company. Lafargeholcim currently has an average rating of Hold and a consensus price target of CHF 51.57.

Lafargeholcim has a twelve month low of CHF 50.40 and a twelve month high of CHF 60.

Recommended Story: Should I follow buy, hold and sell recommendations?

Analyst Recommendations for Lafargeholcim (VTX:LHN)

Friday, March 8, 2019

ETSY Stock Slides, Then Recovers, Following Investor Day Update

ETSY stock was on a wild ride Friday following the release of its Investor Day update.

ETSY Stock Slides, Then Recovers, Following Investor Day UpdateETSY Stock Slides, Then Recovers, Following Investor Day UpdateSource: Shutterstock

The Investor Day update from Etsy (NASDAQ:ETSY) has the company providing information about its long-term goals and five-year plans for the company. While the company is expecting strong growth during this period, it may not be enough to satisfy investors.

Starting off, Etsy says that it is expecting GMS to increase between 16% and 20% over the next five years. It also notes that it is expecting revenue to grow slightly faster than GMS during this period.

The Investor Day update that has ETSY stock moving today also sees it expecting adjusted EBITDA margins increasing over the next five years. The company says that it expects this to expand to 30% or higher during that time.

“We believe our product improvements and investments lay the foundation for sustained growth over the next five years,” Rachel Glaser, CFO of Etsy, said in a statement. “Etsy has been growing faster than the overall e-commerce market, and this outlook suggests we will continue to grow faster than the market.”

ETSY stock started the day off down about 5% on Thursday. However, the stock managed to climb back up throughout the day and was even up 1% at one point. As of Thursday afternoon, ETSY stock is only up slightly from yesterday’s close. The stock is also up 43% since the start of the year.

As of this writing, William White did not hold a position in any of the aforementioned securities.

Compare Brokers

Thursday, March 7, 2019

Why MarketAxess Holdings Stock Jumped 13.6% in February

What happened

Shares of MarketAxess Holdings (NASDAQ:MKTX) leapt nearly 14% last month, according to data provided by S&P Global Market Intelligence, after the leading electronic fixed-income investment trading platform delivered strong fourth-quarter results and boosted its dividend.

So what

MarketAxess Holdings' fourth-quarter revenue rose 14.1% to $112.4 million, while its earnings per share surged 37.5% to $1.21. Both of those figures came in well ahead of Wall Street's estimates; analysts had expected revenue of $110.7 million and EPS of $1.15.

The gains were fueled by a 24.4% rise in trading volume, to $442.3 billion. This includes a 96.5% surge in volume on MarketAxess' Open Trading platform -- which offers traders a cost-effective way to transact anonymously -- to $117.5 billion.

Better still, MarketAxess continues to gain share in the $40 trillion U.S. bond market. The company's share of the U.S. high-grade market rose to 19.3% in the fourth quarter, up from 17.6% in the year-ago period. Its share of the U.S. high-yield market also improved, rising to 10.9% from 6.3%.

People working at a trading desk.

Bond traders are flocking to MarketAxess' electronic trading platform. Image source: Getty Images.

Now what

Management is committed to returning a sizable portion of MarketAxess' profits to shareholders. The company boosted its quarterly cash dividend by 21% to $0.51 per share. Its board of directors also authorized a new $100 million share repurchase program, which is expected to begin in April.

Moreover, MarketAxess remains well positioned to benefit from the trend toward electronic trading. With its shares pulling back about 6% so far in March, long-term investors may want to use the stock's recent dip as a buying opportunity.

Wednesday, March 6, 2019

Q1 2019 EPS Estimates for TiVo Corp Decreased by B. Riley (TIVO)

TiVo Corp (NASDAQ:TIVO) – Equities research analysts at B. Riley reduced their Q1 2019 earnings per share (EPS) estimates for TiVo in a report issued on Wednesday, February 27th. B. Riley analyst E. Wold now forecasts that the technology company will post earnings per share of $0.10 for the quarter, down from their previous forecast of $0.16. B. Riley also issued estimates for TiVo’s Q2 2019 earnings at $0.10 EPS, Q3 2019 earnings at $0.10 EPS, Q4 2019 earnings at $0.11 EPS, FY2019 earnings at $0.41 EPS, Q1 2020 earnings at $0.12 EPS, Q2 2020 earnings at $0.12 EPS, Q3 2020 earnings at $0.13 EPS, Q4 2020 earnings at $0.14 EPS and FY2020 earnings at $0.51 EPS.

Get TiVo alerts:

TiVo (NASDAQ:TIVO) last posted its quarterly earnings data on Tuesday, February 26th. The technology company reported ($2.33) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.28 by ($2.61). TiVo had a negative net margin of 5.76% and a positive return on equity of 4.65%. The business had revenue of $168.46 million for the quarter, compared to analysts’ expectations of $173.68 million. During the same quarter in the previous year, the firm earned $0.47 EPS. TiVo’s revenue was down 21.4% compared to the same quarter last year.

Several other equities research analysts have also recently weighed in on TIVO. ValuEngine cut TiVo from a “sell” rating to a “strong sell” rating in a report on Thursday, November 8th. Zacks Investment Research upgraded TiVo from a “hold” rating to a “buy” rating and set a $12.00 target price for the company in a report on Friday, November 16th. Finally, BidaskClub upgraded TiVo from a “sell” rating to a “hold” rating in a report on Thursday, December 13th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $17.67.

Shares of TIVO stock opened at $9.79 on Monday. TiVo has a twelve month low of $8.73 and a twelve month high of $15.32. The firm has a market capitalization of $1.41 billion, a price-to-earnings ratio of 19.58 and a beta of 0.09. The company has a debt-to-equity ratio of 0.55, a current ratio of 3.55 and a quick ratio of 3.49.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 26th. Shareholders of record on Tuesday, March 12th will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 7.35%. The ex-dividend date is Monday, March 11th. TiVo’s dividend payout ratio is 144.00%.

Several hedge funds have recently modified their holdings of TIVO. Oregon Public Employees Retirement Fund purchased a new stake in shares of TiVo in the 4th quarter worth $47,000. Meridian Wealth Management LLC purchased a new stake in shares of TiVo in the 4th quarter worth $107,000. Amundi Pioneer Asset Management Inc. purchased a new stake in shares of TiVo in the 4th quarter worth $117,000. Magnus Financial Group LLC purchased a new stake in shares of TiVo in the 4th quarter worth $151,000. Finally, Stone Ridge Asset Management LLC bought a new position in shares of TiVo in the 3rd quarter worth $162,000. Institutional investors and hedge funds own 94.04% of the company’s stock.

About TiVo

TiVo Corporation provides media and entertainment products for the consumer entertainment industry worldwide. The company operates in two segments, Product and Intellectual Property Licensing. The Product segment offers platform solutions, such as TiVo Service Platform, a cloud-based service that powers the TiVo Service client software, which operates on set-top boxes in consumer homes, as well as applications that operate on third party software platforms, such as iOS and Android; user experience solutions that allow service providers to customize elements of the interactive program guides for their customers, as well as to upgrade their programming features and services under the G-GUIDE brand; and CubiTV and TiVo Lite middleware solutions for pay TV service providers comprising cable, satellite, terrestrial, and telecommunications operators.

Featured Article: Why is Cost of Capital Important?

Earnings History and Estimates for TiVo (NASDAQ:TIVO)

Tuesday, March 5, 2019

Mplx Lp (MPLX) Receives Average Recommendation of “Buy” from Analysts

Mplx Lp (NYSE:MPLX) has been assigned an average recommendation of “Buy” from the fifteen ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $41.20.

Several equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Mplx from a “buy” rating to a “hold” rating in a research report on Tuesday, February 12th. UBS Group lowered their price objective on shares of Mplx to $41.00 and set an “overweight” rating on the stock in a research report on Thursday, February 7th. Bank of America reiterated a “neutral” rating and set a $41.00 price objective (up from $36.00) on shares of Mplx in a research report on Thursday, December 6th. ValuEngine upgraded shares of Mplx from a “strong sell” rating to a “sell” rating in a research report on Wednesday, January 2nd. Finally, Citigroup lowered their price objective on shares of Mplx from $44.00 to $40.00 and set a “buy” rating on the stock in a research report on Thursday, November 29th.

Get Mplx alerts:

Mplx stock traded up $0.02 during mid-day trading on Friday, hitting $33.18. The company’s stock had a trading volume of 1,461,439 shares, compared to its average volume of 1,892,685. The company has a debt-to-equity ratio of 1.85, a quick ratio of 0.70 and a current ratio of 0.77. The firm has a market cap of $26.73 billion, a price-to-earnings ratio of 14.49, a price-to-earnings-growth ratio of 2.24 and a beta of 1.34. Mplx has a twelve month low of $28.32 and a twelve month high of $39.01.

Mplx (NYSE:MPLX) last posted its quarterly earnings results on Thursday, February 7th. The pipeline company reported $0.52 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.68 by ($0.16). The business had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.72 billion. Mplx had a return on equity of 26.12% and a net margin of 28.30%. The company’s quarterly revenue was up 58.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.31 EPS. As a group, equities analysts predict that Mplx will post 2.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 14th. Shareholders of record on Tuesday, February 5th were given a dividend of $0.6475 per share. This represents a $2.59 annualized dividend and a yield of 7.81%. This is a boost from Mplx’s previous quarterly dividend of $0.64. The ex-dividend date of this dividend was Monday, February 4th. Mplx’s payout ratio is presently 113.10%.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Lindbrook Capital LLC acquired a new stake in shares of Mplx during the 4th quarter valued at $28,000. Executive Wealth Management LLC acquired a new stake in shares of Mplx during the 4th quarter valued at $46,000. We Are One Seven LLC acquired a new stake in shares of Mplx during the 4th quarter valued at $52,000. IFP Advisors Inc boosted its stake in shares of Mplx by 65.0% during the 4th quarter. IFP Advisors Inc now owns 2,543 shares of the pipeline company’s stock valued at $77,000 after buying an additional 1,002 shares during the period. Finally, Belpointe Asset Management LLC acquired a new stake in shares of Mplx during the 3rd quarter valued at $104,000. Hedge funds and other institutional investors own 30.78% of the company’s stock.

Mplx Company Profile

MPLX LP owns, operates, develops, and acquires midstream energy infrastructure assets. It operates in two segments, Logistics and Storage, and Gathering and Processing segments. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, storage, and marketing of natural gas liquids (NGLs); and gathering, transportation, and storage of crude oil and refined petroleum products.

Further Reading: What are the economic characteristics of a bear market?

Analyst Recommendations for Mplx (NYSE:MPLX)

Monday, March 4, 2019

Oaktree Specialty Lending Corp (OCSL) Director Craig A. Jacobson Buys 19,160 Shares

Oaktree Specialty Lending Corp (NASDAQ:OCSL) Director Craig A. Jacobson bought 19,160 shares of the business’s stock in a transaction on Thursday, February 28th. The stock was bought at an average price of $5.22 per share, with a total value of $100,015.20. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of Oaktree Specialty Lending stock traded down $0.04 during midday trading on Friday, reaching $5.16. 327,767 shares of the company’s stock traded hands, compared to its average volume of 434,029. The company has a market capitalization of $741.45 million, a P/E ratio of 12.00, a P/E/G ratio of 5.44 and a beta of 0.58. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.45. Oaktree Specialty Lending Corp has a 52 week low of $4.08 and a 52 week high of $5.29.

Get Oaktree Specialty Lending alerts:

Oaktree Specialty Lending (NASDAQ:OCSL) last released its quarterly earnings results on Thursday, February 7th. The credit services provider reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. The business had revenue of $38.28 million for the quarter, compared to the consensus estimate of $36.80 million. Oaktree Specialty Lending had a net margin of 73.31% and a return on equity of 7.54%. On average, equities research analysts predict that Oaktree Specialty Lending Corp will post 0.48 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Friday, March 15th will be issued a dividend of $0.095 per share. The ex-dividend date of this dividend is Thursday, March 14th. This represents a $0.38 dividend on an annualized basis and a dividend yield of 7.36%. Oaktree Specialty Lending’s dividend payout ratio is currently 88.37%.

A number of equities research analysts have issued reports on the stock. JMP Securities increased their target price on shares of Oaktree Specialty Lending from $5.50 to $5.75 and gave the stock a “market outperform” rating in a research report on Monday, December 17th. ValuEngine upgraded shares of Oaktree Specialty Lending from a “hold” rating to a “buy” rating in a research report on Friday, February 8th. TheStreet upgraded shares of Oaktree Specialty Lending from a “c+” rating to a “b” rating in a research report on Monday, February 4th. Zacks Investment Research upgraded shares of Oaktree Specialty Lending from a “sell” rating to a “hold” rating in a research report on Tuesday, February 12th. Finally, National Securities reiterated a “neutral” rating and issued a $5.00 target price on shares of Oaktree Specialty Lending in a research report on Monday, December 3rd. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $5.79.

Several institutional investors have recently added to or reduced their stakes in the company. River Road Asset Management LLC grew its position in Oaktree Specialty Lending by 4.0% in the 3rd quarter. River Road Asset Management LLC now owns 6,969,793 shares of the credit services provider’s stock worth $34,570,000 after purchasing an additional 270,487 shares during the last quarter. Private Management Group Inc. grew its position in Oaktree Specialty Lending by 0.9% in the 4th quarter. Private Management Group Inc. now owns 4,793,599 shares of the credit services provider’s stock worth $20,277,000 after purchasing an additional 44,677 shares during the last quarter. Bruni J V & Co. Co. grew its position in Oaktree Specialty Lending by 28.3% in the 4th quarter. Bruni J V & Co. Co. now owns 3,958,176 shares of the credit services provider’s stock worth $16,743,000 after purchasing an additional 872,638 shares during the last quarter. Hilton Capital Management LLC grew its position in Oaktree Specialty Lending by 24.6% in the 3rd quarter. Hilton Capital Management LLC now owns 3,957,659 shares of the credit services provider’s stock worth $19,630,000 after purchasing an additional 780,594 shares during the last quarter. Finally, Bayview Asset Management LLC acquired a new stake in Oaktree Specialty Lending in the 4th quarter worth $10,802,000. Institutional investors and hedge funds own 45.77% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Oaktree Specialty Lending Corp (OCSL) Director Craig A. Jacobson Buys 19,160 Shares” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/4188917/oaktree-specialty-lending-corp-ocsl-director-craig-a-jacobson-buys-19160-shares.html.

Oaktree Specialty Lending Company Profile

Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies.

Read More: Gross Domestic Product (GDP)

Insider Buying and Selling by Quarter for Oaktree Specialty Lending (NASDAQ:OCSL)